Ghazal, O., Al-Shalchy, A. (2022). Benefits of using Programmable Lumboperitoneal Shunt in the Management of Idiopathic Intracranial Hypertension. , 21(1), 38-45. doi: 10.52573/ipmj.2021.174069
Omar Mohsin Mohammed Ghazal; Ali Kamil Al-Shalchy. "Benefits of using Programmable Lumboperitoneal Shunt in the Management of Idiopathic Intracranial Hypertension". , 21, 1, 2022, 38-45. doi: 10.52573/ipmj.2021.174069
Ghazal, O., Al-Shalchy, A. (2022). 'Benefits of using Programmable Lumboperitoneal Shunt in the Management of Idiopathic Intracranial Hypertension', , 21(1), pp. 38-45. doi: 10.52573/ipmj.2021.174069
Ghazal, O., Al-Shalchy, A. Benefits of using Programmable Lumboperitoneal Shunt in the Management of Idiopathic Intracranial Hypertension. , 2022; 21(1): 38-45. doi: 10.52573/ipmj.2021.174069

Benefits of using Programmable Lumboperitoneal Shunt in the Management of Idiopathic Intracranial Hypertension

Iraqi Postgraduate Medical Journal
Article 6, Volume 21, Issue 1, 2022, Pages 38-45    PDF (238.9 K)
Document Type: Research Paper
DOI: 10.52573/ipmj.2021.174069
Authors
Omar Mohsin Mohammed Ghazal1; Ali Kamil Al-Shalchy2
1Tikrit Emergency Hospital / Saladdin, Iraq.
2Ghazi Al-Hariri Teaching Hospital for Specialized Surgery / Baghdad Medical City/ Baghdad, Iraq.
Abstract
BACKGROUND:
Idiopathic intracranial hypertension (IIH) is a neurological disorder that requires the use of lumboperitoneal (LP) shunt which is the procedure of choice for most surgeons.
AIM OF THE STUDY:
To assess the benefits of using a programmable LP shunt in the treatment of IIH, and how to reach the optimal final performance level with minimal shunt-related complications.
PATIENTS AND METHODS:
A prospective single-center study of 30 patients diagnosed with IIH, treated with adjustable LP shunt in the neurosurgical department at the teaching Martyr Ghazi Al-Hariri Hospital for Specialized Surgery for a period extending from August 30th, 2017 till November 21st, 2018.
RESULTS:
Among the included patients in the study (30 patients), the female:male ratio was 9:1 with an age range of 17-50 years. Most of the cases (40%) were presented with BMI more than 35. The opening pressure was within the range of 280-585 mmH2O. For the final performance level (P/L), 67% ended up with P/L 1.5 and 27% ended up with P/L 2.0. The outcome recorded as headache improvement 97% and visual improvement 85%. The complications were CSF collection 10%, infection 3%, and the need for shunt revision 7%.
CONCLUSION:
Using the adjustable Medtronic Strata NSC valve has the possibility of avoiding shunt-related complications with better outcomes.
 
Keywords
Idiopathic intracranial hypertension (IIH); Strata NSC valve; adjustable LP shunt
References
  1. Friedman DI. The pseudotumor cerebri syndrome. Neurol Clin. 2014; 32:363-96.
  2. Wall M. Update on Idiopathic Intracranial Hypertension. Neurologic Clinics. 2017; 35:46.
  3. Greenberg MS. Handbook of Neurosurgery. 8th ed. New York: Thieme Medical Publishers. 2016; 766.
  4. Wakerley BR, Tan MH, Ting EY. Idiopathic intracranial hypertension. Cephalalgia: An International Journal of Headache. 2015: 35:248–61.
  5. Gary YS, Stephanie KM. Benign Intracranial Hypertension: A Diagnostic Dilemma. Case Reports in Otolaryngology. 2012; 2012:1-8.
  6. Lee SC, Lueck CJ. Cerebrospinal fluid pressure in adults. J Neuroophthalmol. 2014; 34:278-83.
  7. Winn HR. Youmans & Winn Neurological Surgery. 7th ed. Elsevier. 2017;164:1360-1.
  8. Brazis PW. Clinical review: the surgical treatment of idiopathic pseudotumour cerebri (idiopathic intracranial hypertension). Cephalalgia. 2008; 28:1361-73.
  9. Binder DK, Horton JC, Lawton MT, et al. Idiopathic intracranial hypertension. Neurosurgery. 2004;54:538-52.
10. Giridharan N, Patel SK, Ojugbeli A, et al. Understanding the complex pathophysiology of idiopathic intracranial hypertension and the evolving role of venous sinus stenting: a comprehensive review of the literature. Neurosurgical Focus FOC. 2021; 45:e10.

11. Plotnik JL, Kosmorsky GS. Operative complications of optic nerve sheath decompression. Ophthalmology. 1993; 100:683–90.

12. Wang VY, Barbaro NM, Lawton MT, et al. Complications of lumboperitoneal shunts. Neurosurgery. 2007;60:1045-49.

13. Nadkarni TD, Rekate HL, Wallace D. Concurrent use of a lumboperitoneal shunt with programmable valve and ventricular access device in the treatment of pseudotumor cerebri: Review of 40 cases. J Neurosurg Pediatr. 2008;2:19-24.

14. Chang CC, Kuwana N, Ito S. Management of patients with normal pressure hydrocephalus by using lumboperitoneal shunt system with the Codman Hakim programmable valve. Neurosurg Focus. 1999;7:e8.

15. Aoki N. Lumboperitoneal shunt: clinical applications, complications, and comparison with ventriculoperitoneal shunt. Neurosurgery. 1990; 26:998-1004.

16. Abubaker K, Ali Z, Raza K, et al. Idiopathic intracranial hypertension: lumboperitoneal shunts versus ventriculoperitoneal shunts - case series and literature review. Br J Neurosurg. 2011; 25:94-9.

17. El-Saadany WF, Farhoud A, Zidan I. Lumboperitoneal shunt for idiopathic intracranial hypertension: patients’ selection and outcome. Neurosurgical review. 2012; 35:239-44.

18. Riffaud L, Moughty C, Henaux PL, et al. Acquired Chiari I malformation and syringomyelia after valveless lumboperitoneal shunt in Infancy. Pediatr Neurosurg. 2008; 44:229-33.

19. McGirt MJ, Woodworth G, Thomas G, et al. Cerebrospinal fluid shunt placement for pseudotumor cerebri associated intractable headache: predictors of treatment response and an analysis of long-term outcomes. J Neurosurg. 2004; 101:627-32.

20. Toma AK, Dherijha M, Kitchen ND, et al. Use of lumboperitoneal shunts with the Strata NSC valve: a single-center experience. Journal of neurosurgery. 2010; 113:1304-8.

21. Yadav YR, ParIhar V, Agarwa M, et al. Lumbar peritoneal shunt in idiopathic intracranial hypertension. Turkish neurosurgery. 2012;22:21-6.

22. Alkherayf F, Al-Shaar HA, Awad M. Management of idiopathic intracranial hypertension with a programmable lumboperitoneal shunt: Early experience. Clinical neurology and neurosurgery. 2015;136:5-9.

23. Jusué-Torres I, Hoffberger JB, Rigamonti D. Complications of lumboperitoneal shunts for idiopathic intracranial hypertension. Cureus. 2014; 6:e188.

24. Abd-Ali BS, Abdulnabi AY, Radhee HK. Lumboperitoneal Shunt Clinical Applications & Complications. Mustansiriya Medical Journal. 2013; 12:19-22.

25. El-Saadany WF, Farhoud A, Zidan I. Lumboperitoneal shunt for idiopathic intracranial hypertension: patients’ selection and outcome. Neurosurgical review. 2012; 35:239-44.

Statistics
Article View: 319
PDF Download: 112


Journal Management System. Powered by iJournalPro.com